Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B01AX05	ARIXTRA	B	Fondaparinux sodium - 2.5mg/0.5ml	2.5mg/0.5ml	Injectable solution	5,341,774 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
C03CA01	APO-FUROSEMIDE	G	Furosemide - 40mg	40mg	Tablet, scored	862,747 L.L
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
N03AX12	APO-GABAPENTIN	G	Gabapentin - 300mg	300mg	Capsule	2,527,768 L.L
L01EB01	APO-GEFITINIB	G	Gefitinib - 250mg	250mg	Tablet	87,345,820 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
A10BB12	AMARYL	B	Glimepiride - 1mg	1mg	Tablet	231,141 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 1mg	1mg	Tablet	137,072 L.L
A10BB12	AMARYL	B	Glimepiride - 2mg	2mg	Tablet	233,829 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 2mg	2mg	Tablet	139,760 L.L
A10BB12	AMARYL	B	Glimepiride - 3mg	3mg	Tablet	392,402 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 3mg	3mg	Tablet	215,015 L.L
A10BB12	AMARYL	B	Glimepiride - 4mg	4mg	Tablet	392,402 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 4mg	4mg	Tablet	215,015 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	40,075,575 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
M05BA06	ADROMUX	G	Ibandronic acid - 150mg	150mg	Tablet, coated	821,088 L.L
M01AE01	ADVIL	B	Ibuprofen - 200mg	200mg	Tablet	321,178 L.L
M01AE01	ADVIL LIQUI-GELS	B	Ibuprofen - 200mg	200mg	Capsule	464,970 L.L
M01AE51	ADVIL COLD & SINUS	B	Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg		Caplet, coated	288,926 L.L
M01AE01	ADVIL LIQUI-GELS EXTRA STRENGTH	B	Ibuprofen - 400mg	400mg	Capsule	575,165 L.L
N02AJ08	ASTEFOR	G	Ibuprofen - 400mg, Codeine phosphate hemihydrate - 30mg		Tablet, film coated	935,314 L.L
M01AE01	ALGIFAST PEDIATRIC	B	Ibuprofen Lysine - 20mg/ml	20mg/ml	Suspension	393,746 L.L
M01AE01	ALGIFAST 400	B	Ibuprofen Lysine - 400mg	400mg	Powder for suspension	473,033 L.L
L01EA01	APO-IMATINIB	G	Imatinib - 100mg	100mg	Tablet	18,838,684 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L

...